Annual report pursuant to Section 13 and 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.24.1
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Accrued liabilities:    
General and administrative $ 225 $ 855
Clinical trial related costs 3,574 1,327
Non-clinical research and manufacturing operations 404 1,779
Payroll related 60 4,828
Other accrued expenses 16 34
Total Accrued liabilities $ 4,279 $ 8,823